Active Ingredient(s):Busulfan FDA Approved: * June 26, 1954 Pharm Company: *GLAXOSMITHKLINE Category:Cancer
Busulfan (Myleran, GlaxoSmithKline, Busulfex IV, Otsuka America Pharmaceutical, Inc.) is a chemotherapy drug in use since 1959. It is a cell cycle non-specific alkylating antineoplastic agent, in the class of alkyl sulfonates. Its chemical designation is 1,4-butanediol dimethanesulfonate.
4 Side effects
5 Dosing, administration, and pharmacokinetics
6 Drug interactions
10 External links
* May have multiple approval dates, manufacturers, or labelers.